1298606124237815815

Omidubicel is our advanced cell therapy, currently in Phase 3 development. It offers a potentially lifesaving #bonemarrowtransplant graft for patients with #bloodcancers. Read more: https://t.co/oHUuIGhnr4 https://t.co/fTZeSuDn11